Mkts

CorMedix Inc.

NASDAQ: CRMD
$5.34-0.32 (-5.65%)
As of Nov 5, 1:15 PM ET

Key statistics

Day range
5.295.78
52-week range
5.3013.02
Today
Open5.76
Previous close5.34
Volume73.1K
Valuation
Market cap441.16M
P/E ratio2.36×
EPS (TTM)2.10
Income & risk
Dividend / yield—
Beta1.54
Avg volume1.20M
Discussion

CRMD News

Stories mentioning CRMD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue127,427128,615104,27539,73739,08211,456806.00
Cost of Goods Sold12,00511,1167,5661,8621,5451,070635.00510.00
Gross Profit105,122107,30893,08137,87437,48530,03510,770296.00
Operating Expenses
Research & Development7,2128,5995,0982,4433,1931,727727.00651.00
Sales General & Admin
Total Operating Expenses41,46448,18141,73518,33117,36017,09814,05715,597
Operating Income (Loss)63,65859,12651,34619,54420,12512,936(3,287)(15,301)
Interest Income890.001,560829.00567.00511.00554.00657.00
Interest Expense7.00
Other Expense1,149
Pretax Income55,64556,44752,57620,34920,64413,464(2,777)(14,151)
Tax Provision17,04442,426(55,987)522.000.00
Net Income (Loss)38,60114,020108,56319,82820,64413,464(2,777)(14,151)
Earnings Per Share (Basic)0.48194.721.420.290.32228.20(0.05)(0.25)
Earnings Per Share (Diluted)0.43175.251.260.280.30228.20(0.05)(0.25)
Weighted Average Shares Outstanding (Basic)79,50972.0075,93067,92865,24459.0058,82557,621
Weighted Average Shares Outstanding (Diluted)92,98580.0086,21471,91968,97559.0058,82557,621

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CRMD

CorMedix Inc. (NASDAQ: CRMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRMD. It last traded at $5.34 (Nov 5, 2026, 1:15 PM ET), down 5.7% on the day. That gives CorMedix a market capitalisation of $441.2M and a price-to-earnings ratio of 2.4.

Over the past 52 weeks CRMD has traded between $5.30 and $13.02.

Revenue for the quarter ended Mar 31, 2026 was $127.4M; net income $38.6M. Revenue was up 226% from $39.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$127.4M$38.6M30.3%
Dec 31, 2025$128.6M$14.0M10.9%
Sep 30, 2025$104.3M$108.6M104.1%
Jun 30, 2025$39.7M$19.8M49.9%

From CorMedix’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…